Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
---|
12/22/1998 | US5852058 Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury |
12/22/1998 | US5851832 In vitro growth and proliferation of multipotent neural stem cells and their progeny |
12/22/1998 | US5851828 Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells |
12/22/1998 | US5851822 Inflammation-induced expression of a recombinant gene |
12/22/1998 | US5851818 Condensed plasmid-liposome complex for transfection |
12/22/1998 | US5851814 Human elastate IV |
12/22/1998 | US5851809 Tryptophanyl tRNA Synthetase polynucleotides of Streptococcus |
12/22/1998 | US5851806 Complementary adenoviral systems and cell lines |
12/22/1998 | US5851804 Chimeric kanamycin resistance gene |
12/22/1998 | US5851798 Nucleic acid encoding human GPR14 receptor |
12/22/1998 | US5851786 Product and process to regulate actin polymerization |
12/22/1998 | US5851775 β-catenin, Tcf-4, and APC interact to prevent cancer |
12/22/1998 | US5851636 Ceramic packing with channels for thermal and catalytic beds |
12/22/1998 | US5851529 Recombinant retroviruses |
12/22/1998 | US5851521 Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis |
12/20/1998 | CA2235444A1 Novel compounds |
12/20/1998 | CA2235442A1 Response regulator |
12/20/1998 | CA2235441A1 Novel compounds |
12/20/1998 | CA2235437A1 Novel compounds |
12/20/1998 | CA2235435A1 Novel compounds |
12/20/1998 | CA2235433A1 Novel compounds |
12/20/1998 | CA2235422A1 Novel compounds |
12/20/1998 | CA2218852A1 Expression system for production of therapeutic proteins |
12/18/1998 | CA2239605A1 Novel g-protein coupled receptor (h7tba62) |
12/17/1998 | WO1998057175A1 Inhibition of the src kinase family pathway as a method of treating hbv infection and hepatocellular carcinoma |
12/17/1998 | WO1998056938A1 Lipoproteins as nucleic acid vectors |
12/17/1998 | WO1998056929A1 Dna sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same |
12/17/1998 | WO1998056913A1 Smad6 and uses thereof |
12/17/1998 | WO1998056907A1 Heart and skeleton muscle specific nucleic acid, the production and use thereof |
12/17/1998 | WO1998056906A1 Trimerising module |
12/17/1998 | WO1998056894A1 Electrospraying apparatus and method for introducing material into cells |
12/17/1998 | WO1998056820A1 Hm74a receptor |
12/17/1998 | WO1998056818A1 Human l105 proteins and polynucleotides encoding same |
12/17/1998 | WO1998056817A1 Composition and methods for the treatment of inflammatory diseases |
12/17/1998 | WO1998056423A1 Novel lipid complexes for transferring at least a therapeutically active substance, in particular a polynucleotide into a target cell and use in gene therapy |
12/17/1998 | WO1998056416A1 Immunogenic compositions for induction of anti-tumor immunity |
12/17/1998 | WO1998056405A1 A method of modulating immune response with osteopontin |
12/17/1998 | WO1998056404A1 Cns neuroregenerative compositions and methods of use |
12/17/1998 | WO1998056393A1 Transplantation of immortalized dopamine cells to improve neurological deficits |
12/17/1998 | WO1998056370A2 Therapeutic nanospheres |
12/17/1998 | WO1998046737A3 Cdna for human gdnf and promoter therefor which allows regulated and constitutive expression |
12/17/1998 | WO1998039467A3 Adenovirus vectors specific for cells expressing carcinoembryonic antigen and methods of use thereof |
12/17/1998 | WO1998030586A3 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
12/17/1998 | WO1998023299A3 Radiolabeled dna oligonucleotide, method of preparation and therapeutic uses thereof |
12/17/1998 | CA2303268A1 Therapeutic nanospheres |
12/17/1998 | CA2295982A1 Human l105 proteins and polynucleotides encoding same |
12/17/1998 | CA2293733A1 Mycardium-and skeletal muscle-specific nucleic acid, its preparation and use |
12/17/1998 | CA2293492A1 Cns neuroregenerative compositions and methods of use |
12/17/1998 | CA2293350A1 Inhibition of the src kinase family pathway as a method of treating hbv infection and hepatocellular carcinoma |
12/17/1998 | CA2292339A1 Smad6 and uses thereof |
12/17/1998 | CA2263367A1 Novel lipid complexes for transferring at least a therapeutically active substance, in particular a polynucleotide into a target cell and use in gene therapy |
12/16/1998 | EP0884387A2 Human 7-transmembrane receptor HLWAR77 |
12/16/1998 | EP0884385A1 Intracellular modulators of apoptopic cell death pathways |
12/16/1998 | EP0883688A1 Adapter molecules for targeting viral particles to cells |
12/16/1998 | EP0883687A2 C-c ckr-5, cc-chemikines receptor, derivatives thereof and their uses |
12/16/1998 | EP0883624A1 Tetraether lipids and liposomes containing said lipids, and use of the same |
12/16/1998 | EP0883344A1 Therapeutic molecules generated by trans-splicing |
12/16/1998 | EP0883343A1 Method for treating ischemic tissue |
12/16/1998 | EP0454781B1 Recombinant cells for therapies of infection and hyperproliferative disorders and preparation thereof |
12/15/1998 | US5849997 Vector for integration site independent gene expression in mammalian host cells |
12/15/1998 | US5849903 Antisense oligonucleotides for IL-8 and IL-8 receptor |
12/15/1998 | US5849902 Three component chimeric antisense oligonucleotides |
12/15/1998 | US5849727 Compositions and methods for altering the biodistribution of biological agents |
12/15/1998 | US5849719 Method for treating allergic lung disease |
12/15/1998 | US5849708 Promotion of eating behavior |
12/15/1998 | US5849586 Infective protein delivery system |
12/15/1998 | US5849578 Compositions and methods for the treatment and diagnosis of cardiovascular using RCHD528 as a target |
12/15/1998 | US5849572 HSV-1 vector containing a lat promoter |
12/15/1998 | US5849571 Latency active herpes virus promoters and their use |
12/15/1998 | US5849561 Method for the production of non-group C adenoviral vectors |
12/15/1998 | US5849514 Method of identifying agents that modulate UCP2 promoter activity |
12/15/1998 | US5849509 Nuclear matrix proteins |
12/15/1998 | US5849493 Screening assay for compounds stimulating somatostatin transcription factor -1 binding to an STF-1 binding site |
12/15/1998 | US5849482 Crosslinking oligonucleotides |
12/15/1998 | US5849297 Modified human C3 proteins |
12/15/1998 | US5849287 Gene therapy using stromal cells |
12/15/1998 | US5849285 Autoimmune disease treatment with sertoli cells and in vitro co-culture of mammal cells with sertoli cells |
12/15/1998 | US5849283 Human interleukin-6 receptor antagonists |
12/15/1998 | CA2144513C Morphogen-induced periodontal tissue regeneration |
12/13/1998 | CA2234424A1 Novel compounds |
12/11/1998 | CA2233584A1 7tm receptor hlwar77 |
12/11/1998 | CA2230998A1 Cdna clone hapoi67 that encodes a human 7-transmembrane receptor |
12/10/1998 | WO1998055646A1 23s rna nucleotide fragment of the clhamydia genus bacteria, uses as probe, primer, and in a reagent and a detection and a detection method |
12/10/1998 | WO1998055641A2 Somatic gene therapy to suppress secondary cataract formation |
12/10/1998 | WO1998055639A2 Recombinant adenoviral vectors comprising a splicing sequence |
12/10/1998 | WO1998055638A1 Regulatory sequences capable of conferring expression of a heterologous dna sequence in endothelial cells in vivo and uses thereof |
12/10/1998 | WO1998055623A1 Type-1 ribosome-inactivating protein |
12/10/1998 | WO1998055621A1 Ntn-2 member of tnf ligand family |
12/10/1998 | WO1998055619A1 Anti-gpiib/iiia recombinant antibodies |
12/10/1998 | WO1998055611A1 Neuregulin response element and uses therefor |
12/10/1998 | WO1998055609A1 Inhibitors of dna immunostimulatory sequence activity |
12/10/1998 | WO1998055607A2 Tumor targeted vector |
12/10/1998 | WO1998055606A2 Lactoferrin receptor genes of moraxella |
12/10/1998 | WO1998055603A1 New selection marker |
12/10/1998 | WO1998055598A1 A METHOD OF INHIBITING CANCER CELL GROWTH USING A VECTOR EXPRESSING pRb2/p130 |
12/10/1998 | WO1998055512A2 Smad-interacting polypeptides and their use |
12/10/1998 | WO1998055507A2 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and kinase domain |
12/10/1998 | WO1998055495A2 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
12/10/1998 | WO1998055490A1 Novel class of nucleic acid cationic transfecting agents |
12/10/1998 | WO1998055151A1 Box-dependent myc-interacting protein (bin1) compositions and uses therefor |